CING - Latest News
Cingulate Inc. (CING), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $27.8M. Beta to the broader market is -0.85.
The article list below shows the most recent CING headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CING Headlines
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
globenewswire.com - Jun 16, 2026
KANSAS CITY, Kan. , June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc.
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
newsfilecorp.com - Jun 4, 2026
Dallas, Texas--(Newsfile Corp. - June 4, 2026) - Cingulate Inc.
US FDA declines to approve Cingulate's ADHD drug
reuters.com - Jun 2, 2026
Cingulate said on Tuesday that the U. S.
Cingulate Receives Complete Response Letter from FDA for CTx-1301
globenewswire.com - Jun 2, 2026
No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related Requests Company Plans Prompt Response
Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301
globenewswire.com - May 14, 2026
KANSAS CITY, Kan. , May 14, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc.
How News Affects CING Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CING's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CING news questions
- What is the latest CING news headline?
- The most recent CING headline (Jun 16, 2026) is "Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CING news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CING news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CING options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.